Only 5–10% of functional protein result from transcription of SMN2. Thus, the severity of symptoms in SMA largely depends on the SMN2 copy number, however, there are other genetic modifiers [3]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.